APT Medical Inc.
688617
Pozycja w akcjach
#3232
APT Medical Inc. is a global enterprise dedicated to the research, development,... APT Medical Inc. is a global enterprise dedicated to the research, development, production, and commercialization of invasive interventional medical devices primarily targeting cardiovascular and cerebrovascular diseases. Its extensive product portfolio encompasses a range of electrophysiological tools, including catheter delivery systems, alongside radiofrequency ablation and mapping catheters. Additionally, APT Medical provides various vascular intervention solutions, spanning diagnostic and therapeutic devices, as well as essential intervention accessories. Beyond its proprietary offerings, the company extends its expertise through OEM (Original Equipment Manufacturer) and ODM (Original Design Manufacturer) services for catheter and metal-based products, including associated accessories. Established in 2002, APT Medical maintains its corporate headquarters in Shenzhen, China.
Cena akcji
$38.62
Kapitalizacja rynkowa
$5.47B
Zmiana (1 dzień)
0.19%
Zmiana (1 rok)
-17.07%
Kraj
CN
Handel APT Medical Inc. (688617)
Kategoria
Healthcare
Zyski dla APT Medical Inc. (688617)
Zyski w Jun 2026 TTM: $158.75M
Według najnowszych raportów finansowych APT Medical Inc., obecny zysk firmy wynosi $158.75M. W roku 2024 firma osiągnęła zysk w wysokości $102.20M, wzrost w porównaniu do zysku z roku 2023, który wynosił $84.25M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy APT Medical Inc. od 2017 do 2026
Zyski na koniec każdego roku
| Rok | Zyski | Zmień |
|---|---|---|
| 2026 (TTM) | $158.75M | 18.63% |
| 2025 | $133.82M | 30.94% |
| 2024 | $102.20M | 21.31% |
| 2023 | $84.25M | 47.08% |
| 2022 | $57.28M | 64.33% |
| 2021 | $34.86M | 87.86% |
| 2020 | $18.55M | 41.43% |
| 2019 | $13.12M | 288.78% |
| 2018 | $3.37M | -29.16% |
| 2017 | $4.76M | 0.00% |
Zyski podobnych firm lub konkurentów
| Firma | Zyski | Różnica w zyskach | Kraj |
|---|---|---|---|
| $6.56B | 4,033.47% |
US
|
|
| $6.60B | 4,059.29% |
IE
|
|
| $5.15B | 3,142.78% |
US
|
|
| $3.86B | 2,332.08% |
US
|
|
| $3.25B | 1,947.21% |
DE
|
